AbbVie's US$100b Drug Pricing Pact Reshapes Growth And Policy Outlook [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
AbbVie (NYSE:ABBV) announced a multi year voluntary agreement with the U.S. government to support access and affordability of medicines. The company committed $100b to U.S. based research and development and capital investments, alongside expanded manufacturing and direct to patient delivery. The agreement is tied to a broader federal policy initiative on drug pricing with potential implications for industry wide pricing and access models. AbbVie enters this agreement with the U.S. government while its shares trade at $223.01 and the company's 1 year return stands at 25.3%. Over longer periods, NYSE:ABBV has returned 71.2% over 3 years and 148.4% over 5 years. These figures illustrate why investors may closely monitor any policy related developments. The move links AbbVie's capital plans with an area of high political and public focus: drug affordability in the U.S. For you as an investor, the scale of the $100b U.S. commitment and the connection to drug pricing policy could
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie Inc. (ABBV) Achieves Record Net Sales on Diversified Growth Platform [Yahoo! Finance]Yahoo! Finance
- AbbVie (NYSE:ABBV) was upgraded by analysts at UBS Group AG to a "hold" rating.MarketBeat
- AbbVie sues US health agency over Botox price controls [Yahoo! Finance Canada]Yahoo! Finance Canada
- AbbVie (NYSE:ABBV) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.MarketBeat
- AbbVie (NYSE:ABBV) was given a new $230.00 price target on by analysts at UBS Group AG.MarketBeat
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 2/4/26 - Form 8-K
- 1/7/26 - Form 8-K
- 1/5/26 - Form 4
- ABBV's page on the SEC website